Dr. Fama on GBV-C Infection and Risk of Lymphoma

Angelo Fama, MD
Published Online: Saturday, Jun 17, 2017



Angelo Fama, MD, Division of Hematology, Mayo Clinic, discusses a case control study of the GB Virus-C (GBV-C) infection and the risk of lymphoma.

According to Fama, after several studies it was demonstrated that the GBV-C infection is replicated in the B and T cells.

After the case-controlled study, it was shown that there was an association between GBV-C and risk for each major lymphoma subtype excluding Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), states Fama.
<<< More from the International Conference on Malignant Lymphoma


Angelo Fama, MD, Division of Hematology, Mayo Clinic, discusses a case control study of the GB Virus-C (GBV-C) infection and the risk of lymphoma.

According to Fama, after several studies it was demonstrated that the GBV-C infection is replicated in the B and T cells.

After the case-controlled study, it was shown that there was an association between GBV-C and risk for each major lymphoma subtype excluding Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), states Fama.
<<< More from the International Conference on Malignant Lymphoma

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Redefining Treatment Paradigms in the Management of Chronic Lymphocytic LeukemiaOct 05, 20172.0
Publication Bottom Border
Border Publication
$emailPop$